For Pharmacy Staff

Medicare GLP-1 Bridge

Live starting July 1, 2026
What it is: A new short-term CMS program that lets certain Medicare Part D patients get a GLP-1 for weight management even though their Part D plan won't cover it. It runs outside of Part D — separate BIN/PCN, separate claim, separate $50 copay. It's only for weight management — patients with type 2 diabetes, moderate-to-severe sleep apnea, or MASH/fatty liver disease should still go through their normal Part D coverage.

Routing the Claim

BIN / PCN

BIN
028918
PCN
MEDDGLP1BR

ID Needed

You need the patient's Medicare Beneficiary Identifier (MBI) — the number on their red, white, and blue Medicare card.
Sample Medicare card showing the Medicare Number (MBI) circled
The MBI is the number under "Medicare Number" — not the SSN.
Eligibility Check screen showing where to enter the patient's last 4 SSN digits and where the returned MBI appears
No card on hand? Ask for the last 4 of their SSN to look up the MBI via Eligibility Check.

Cost & Fill Limits

$50
Copay collected from every patient Even patients with Extra Help (LIS) still pay $50. Doesn't count toward Part D deductible or TrOOP.
1 month
Max supply per fill (28 or 30 days)

Eligible Products

Wegovy® oral & injectable, all formulations
Zepbound® KwikPen® KwikPen only
Foundayo® tablet, all formulations
Not covered: Zepbound single-dose pen or vials — those reject under the Bridge.

⚠ Patient name must match the Medicare card

The claim is verified against Medicare's records, not just your patient profile. If the name on file doesn't match the patient's Medicare card exactly (nickname, maiden name, recent legal name change, etc.), the claim can reject. Update the patient's name in your system to match the card before submitting.

Clinical Criteria (for reference)

Clinical criteria for coverage under the Medicare GLP-1 Bridge: provider attestation of age 18+, ongoing lifestyle modification, no type 2 diabetes/moderate-severe OSA/MASH, and BMI 27+, 30+, or 35+ thresholds with qualifying comorbidities

This is determined by the prescriber during prior authorization — pharmacy staff don't need to verify it, but it's useful context for why a claim may be denied or why a prescriber is asked to attest to it.